脓毒症并发毛细血管渗漏综合征的研究进展

doi:10.16352/j.issn.1001-6325.2022.07.1144

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (7): 1144-1147.doi: 10.16352/j.issn.1001-6325.2022.07.1144

脓毒症并发毛细血管渗漏综合征的研究进展

林柏柏¹, 钱风华², 钱义明², 赵雷², 孙旗¹, 褚梦瑶¹, 沈梦雯^2*

1.上海中医药大学,上海 200080;
2.上海中医药大学附属岳阳中西医结合医院急诊医学科,上海 200437

收稿日期:2020-10-26 修回日期:2021-04-06 出版日期:2022-07-05 发布日期:2022-06-29
通讯作者: * hupo_58@163.com
基金资助:
上海中医药大学附属岳阳中西医结合医院基金青年项目(2019YYQ07)

Research progress of sepsis complicated with capillary leakage syndrome

LIN Bai-bai¹, QIAN Feng-hua², QIAN Yi-ming², ZHAO Lei², SUN Qi¹, CHU Meng-yao¹, SHEN Meng-wen^2*

1. Shanghai University of Traditional Chinese Medicine, Shanghai 200080;
2. Department of Emergency Medicine, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

Received:2020-10-26 Revised:2021-04-06 Online:2022-07-05 Published:2022-06-29
Contact: * hupo_58@163.com

摘要/Abstract

摘要： 脓毒症(sepsis)具有高发病率,是一种常见的、可致命的疾病。脓毒症是指因感染引起的宿主反应失调导致危及生命的器官功能障碍,部分患者还会出现低蛋白血症、低血压、少尿、水肿等现象,即毛细血管渗漏综合征(CLS)。脓毒症合并CLS是较复杂的疾病,对于此类患者,需要给予积极的治疗,然治疗讲究针对性、有效性,因此,深入理解此疾病的发病机制,并且结合临床治疗经验对临床工作有重要的意义。

关键词: 脓毒症, 毛细血管渗漏综合征, 发病机制, 临床治疗

Abstract: Sepsis is a common and fatal disease with high mortality. Sepsis is a life-threatening organ dysfunction caused by abnormal host response to infection. Some patients also complicate with hypo-albuminemia, hypotension, oliguria, edema and other phenomena, namely capillary leakage syndrome (CLS). Sepsis with CLS is a complex disease urgently needs active treatment, but a successful treatment must be based on in-depth understanding of the pathogenesis and combined with clinical treatment experience.

Key words: sepsis, capillary leakage syndrome, pathogenesis, clinical treatment

中图分类号:

R364

林柏柏, 钱风华, 钱义明, 赵雷, 孙旗, 褚梦瑶, 沈梦雯. 脓毒症并发毛细血管渗漏综合征的研究进展[J]. 基础医学与临床, 2022, 42(7): 1144-1147.

LIN Bai-bai, QIAN Feng-hua, QIAN Yi-ming, ZHAO Lei, SUN Qi, CHU Meng-yao, SHEN Meng-wen. Research progress of sepsis complicated with capillary leakage syndrome[J]. Basic & Clinical Medicine, 2022, 42(7): 1144-1147.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/10.16352/j.issn.1001-6325.2022.07.1144

http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/Y2022/V42/I7/1144

参考文献 28

[1]	Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016, 315: 801-810.
[2]	Ma S, Evans RG, Iguchi N, et al. Sepsis-induced acute kidney injury: a disease of the microcirculation[J]. Microcirculation, 2019, 26: e12483. doi: 10.1111/micc.12483.
[3]	Hajare KR, Patil P, Bansode J. Idiopathic systemic capillary leak syndrome[J]. Indian J Crit Care Med, 2018, 22: 369-371.
[4]	Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome: etiologies, pathophysiology, and management[J]. Kidney Int, 2017, 92: 37-46.
[5]	Mertz P, Lebrun-Vignes B, Salem JE, et al. Characteriz-ing drug-induced capillary leak syndromes using the World Health Organization VigiBase[J]. J Allergy Clin Immunol, 2019, 143: 433-436.
[6]	Xie Z, Ghosh CC, Patel R, et al. Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome)[J]. Blood, 2012, 119: 4321-4332.
[7]	Xu D, Liu T, Lin L, et al. Exposure to endosulfan increases endothelial permeability by transcellular and paracellular pathways in relation to cardiovascular diseases[J]. Environ Pollut, 2017, 223: 111-119.
[8]	Takeuchi O, Akira S. Pattern recognition receptors and inflammation[J]. Cell, 2010, 140: 805-820.
[9]	D'Elia RV, Harrison K, Oyston PC, et al. Targeting the “cytokine storm” for therapeutic benefit[J]. Clin Vaccine Immunol, 2013, 20: 319-327.
[10]	Raymond SL, Holden DC, Mira JC, et al. Microbial recognition and danger signals in sepsis and trauma[J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863: 2564-2573.
[11]	Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nat Immunol, 2010, 11: 373-384.
[12]	Akwii RG, Sajib MS, Zahra FT, et al. Role of angiopoietin-2 in vascular physiology and pathophysiology[J]. Cells, 2019, 8: 471.doi:10.3390/cells8050471.
[13]	Druey KM, Parikh SM. Idiopathic systemic capillary leak syndrome (Clarkson disease)[J]. J Allergy Clin Immunol, 2017, 140: 663-670.
[14]	Geranmayeh MH, Rahbarghazi R, Farhoudi M. Targeting pericytes for neurovascular regeneration[J]. Cell Commun Signal, 2019, 17: 26. doi: 10.1186/s12964-019-0340-8.
[15]	Claesson-Welsh L. Vascular permeability--the essentials[J]. Ups J Med Sci, 2015, 120:135-143.
[16]	王永玲, 李冬霞, 高建芝, 等.VEGF在肥胖患者乳腺癌组织中的表达及临床意义[J].基础医学与临床, 2012, 32: 544-547.
[17]	Li X, Padhan N, Sjöström EO, et al. VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread[J]. Nat Commun, 2016, 7: 11017. doi:10.1038/ncomms11017.
[18]	Heinolainen K, Karaman S, D'Amico G, et al. VEGFR3 modulates vascular permeability by controlling VEGF/VEGFR2 signaling[J]. Circ Res, 2017, 120: 1414-1425.
[19]	Regula JT, Lundh von Leithner P, Foxton R, et al. Targeting key angiogenic pathways with a bispecific cross-MAb optimized for neovascular eye diseases[J]. EMBO Mol Med, 2016, 8: 1265-1288.
[20]	许小泽, 刘雪燕, 郑标林, 等. 脓毒症毛细血管渗漏综合征的机制及临床治疗探究[J].当代医学, 2020, 26: 189-191.
[21]	黄增相, 何超, 陶骅, 等. 肠源性脓毒症并发肺毛细血管渗漏综合征一例救治[J].中国呼吸与危重监护杂志, 2015, 14: 98-100.
[22]	王晓锋, 瞿金龙. 乌司他丁治疗急性呼吸窘迫综合征的临床研究[J].交通医学, 2019, 33: 574-576.
[23]	陈豆豆, 常青, 章向成, 等. 连续性肾脏替代治疗对严重脓毒症患者肾功能及微循环的影响[J]. 广西医科大学学报, 2017, 34: 851-854.
[24]	Das M, Karnam A, Stephen-Victor E, et al. Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy[J]. Cell Death Dis,2020,11: 50. doi: 10.1038/s41419-020-2249-y.
[25]	贺周香. 免疫球蛋白对脓毒症患者血管内皮功能的影响[J].中外医学研究, 2019, 17: 52-53.
[26]	Liu S, Yao C, Zhang J, et al. Efficacy of Xuebijing Injection for sepsis (EXIT-SEP): protocol for a randomised controlled trial[J]. BMJ Open, 2019, 9: e028664. doi: 10.1136/bmjopen-2018-028664.
[27]	张利鹏, 张立彦, 王雪芳, 等. 血必净联合西医治疗老年毛细血管渗漏综合征的疗效及对血压、血清炎症因子的影响[J].实用老年医学, 2017, 31: 462-465.
[28]	Chen G, Gao Y, Jiang Y, et al. Efficacy and safety of xuebijing injection combined with ulinastatin as adjunctive therapy on sepsis: a systematic review and meta-analysis[J]. Front Pharmacol, 2018, 9: 743. doi: 10.3389/fphar.2018.00743.

脓毒症并发毛细血管渗漏综合征的研究进展

Research progress of sepsis complicated with capillary leakage syndrome

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 28

相关文章 15

编辑推荐

Metrics

本文评价

[1]	薛晋芳, 宋海飞, 陈国兵. 程序性细胞死亡在脓毒症发生发展中的研究进展[J]. 基础医学与临床, 2022, 42(8): 1284-1287.
[2]	匡重伸, 丛竹凯, 吴长毅, 杨宁, 宗亚楠, 郭向阳. 内脂素在脓毒症相关性脏器损伤中的作用及机制研究进展[J]. 基础医学与临床, 2022, 42(8): 1279-1283.
[3]	赵肖灵, 何润之, 孙玉姣, 张小冲, 杨林芳, 王瑞, 程芳. 活动期白癜风患者血清γ干扰素含量升高[J]. 基础医学与临床, 2022, 42(7): 1067-1070.
[4]	温燕, 林金灿, 黄颖泓, 肖文彪, 张民伟, 林建东. 脓毒症早期BMP-2和BMP-4的变化[J]. 基础医学与临床, 2022, 42(4): 628-632.
[5]	王行行, 王导新. NETs与急性呼吸窘迫综合征的研究进展[J]. 基础医学与临床, 2021, 41(7): 1047-1051.
[6]	王玉龙, 滕文彬, 单跃, 姚刘旭, 何锐, 李玉红, 祝胜美. HIF-1α激动剂或拮抗剂对脓毒症大鼠肠道黏膜通透性的影响[J]. 基础医学与临床, 2021, 41(11): 1618-1623.
[7]	邵瑞飞, 杨艳, 郑志榕, 赵世民, 陈国兵. 肠道菌群和“肠-肺”轴在脓毒症中的作用[J]. 基础医学与临床, 2020, 40(8): 1109-1112.
[8]	兰菲, 刘太阳, 杨杰. 肠离子通道在肠易激综合征发病机制中的作用研究进展[J]. 基础医学与临床, 2020, 40(8): 1135-1139.
[9]	何锐, 朱烨柯, 滕文彬, 单跃, 易声华, 祝胜美, 李玉红. 甘油可能通过水通道蛋白3减轻脓毒症小鼠肠黏膜屏障损伤[J]. 基础医学与临床, 2020, 40(5): 655-661.
[10]	文大林, 杜娟, 陈民佳, 孙剑会, 张华才, 张安强, 都定元. 联合检测C反应蛋白和降钙素原在创伤后脓毒症患者早期预警中的作用[J]. 基础医学与临床, 2020, 40(2): 178-181.
[11]	宋华琛唐晓楠张海婧王文杰吴练秋. 结肠炎相关结肠癌机制研究进展[J]. 基础医学与临床, 2018, 38(4): 568-572.
[12]	吴铭蒋苇苇高莉莉. 脂氧素A4降低LPS致肥胖大鼠炎性因子的释放[J]. 基础医学与临床, 2018, 38(12): 1749-1752.
[13]	黄体龙杨跃煌张娴文. 间变性淋巴瘤激酶与神经母细胞瘤[J]. 基础医学与临床, 2018, 38(12): 1791-1794.
[14]	李甜甜张江宇李荔. PI3K/Akt在多囊卵巢综合征发病机制中作用的研究进展[J]. 基础医学与临床, 2016, 36(11): 1596-1602.
[15]	宋庆旭孙锦堂曲迅. 骨髓来源免疫细胞对肿瘤血管生成中的调节及临床应用研究进展[J]. 基础医学与临床, 2013, 33(6): 779-782.